3h8n
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
| - | [[Image:3h8n. | + | [[Image:3h8n.png|left|200px]] |
<!-- | <!-- | ||
| Line 12: | Line 12: | ||
===Crystal Structure Analysis of KIR2DS4=== | ===Crystal Structure Analysis of KIR2DS4=== | ||
| + | |||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_19858347}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 19858347 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_19858347}} | ||
==About this Structure== | ==About this Structure== | ||
3H8N is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3H8N OCA]. | 3H8N is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3H8N OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:19858347</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Bushnell, D A.]] | [[Category: Bushnell, D A.]] | ||
| Line 30: | Line 39: | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Nov 11 22:54:33 2009'' |
Revision as of 20:54, 11 November 2009
Crystal Structure Analysis of KIR2DS4
Template:ABSTRACT PUBMED 19858347
About this Structure
3H8N is a 1 chain structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, Older Aguilar AM, Gleimer M, Hammond JA, Guethlein LA, Bushnell DA, Robinson PJ, Parham P. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med. 2009 Oct 26;206(11):2557-72. PMID:19858347 doi:10.1084/jem.20091010
Page seeded by OCA on Wed Nov 11 22:54:33 2009
